GenEmbryomics Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
, February 9, 2023 (Newswire.com) - RedChip Companies will air a new interview with GenEmbryomics, the first company in the world to offer a comprehensive whole-genome sequencing screening test for in vitro fertilization (IVF), on The RedChip Money Report® on Bloomberg TV, this Saturday, February 11, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.
Interview highlights:
In the exclusive RedChip Money Report interview, GenEmbryomics' CEO Dr. Nick Murphy discusses the Company's revolutionary genetic test for IVF, how the testing can detect de novo mutations, the near-term commercialization strategy, and much more.
Access this interview in its entirety at https://genembryomicsinfo.com/interview_access
About The RedChip Money Report®
The RedChip Money Report® is produced by RedChip Companies Inc., an international Investor Relations and media firm with 30 years' experience focused on Discovering Tomorrow's Blue Chips Today™. "The RedChip Money Report®" delivers insightful commentary on small-cap investing, interviews with Wall Street analysts, financial book reviews, as well as featured interviews with executives of public companies.
About GenEmbryomics
GenEmbryomics is the first company in the world to offer a comprehensive whole-genome sequencing screening test for in vitro fertilization (IVF) embryos, providing a novel way to screen for genetic diseases before pregnancy. De novo mutations spontaneously occurring at fertilization account for over 4,525 genetic diseases that are routinely missed by currently used preimplantation genetic testing.
The Company is employing a B2B business model targeting IVF clinics globally. Initial commercialization plans are focused on the US, Europe, and Middle East, leveraging the key opinion leader status of the Company's Executive Director and Senior Advisor, Dr. Santiago Munné. Dr. Munné developed the first Preimplantation Genetic Diagnosis (PGD) test to detect embryonic numerical chromosome abnormalities to avoid Down's syndrome and other abnormalities and is extremely well-known amongst clinic owners.
About RedChip Companies
RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. For 30 years, RedChip has delivered concrete, measurable results for its clients. Our newsletter, the RedChip Money Report is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, "The RedChip Money Report," which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more.
To learn more about RedChip's products and services, please visit:
https://www.redchip.com/corporate/investor_relations
"Discovering Tomorrow's Blue Chips Today"™
Contact:
Dave Gentry
RedChip Companies Inc.
1-800-RED-CHIP (733-2447)
Or 407-491-4498
GenEmbryomics@redchip.com
SOURCE: RedChip
Source: RedChip